On Jan. 23, the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School and the Center for Advanced Studies in Biomedical Innovation Law (CeBIL) at the University of Copenhagen launched a new collaboration, the Project on Precision Medicine, Artificial Intelligence, and the Law (PMAIL).
This fall, the Harvard Law School Library hosted a series of book talks by HLS authors, with topics ranging from Justice and Leadership in Early Islamic Courts to a Citizen’s Guide to Impeachment. As part of this ongoing series, faculty authors from various disciplines shared their research and discussed their recently published books.
This fall, Glenn Cohen, Harvard Law School professor and faculty director for the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics delivered a talk titled “Are There Non-human Persons? Are There Non-person Humans?,” which explored how law and morality should accommodate animals and artificial intelligence alongside human beings.
While the NFL’s player health policies and practices are robust in some areas, there are opportunities for improvement in others, according to the findings of a new report by researchers at Harvard Law School’s Petrie-Flom Center — the first comprehensive comparative analysis of health policies and practices across professional sports leagues.
Harvard Law School Professor Glenn Cohen co-authored an article for the journal Science Translational Medicine on the legal and ethical considerations regarding in vitro gametogenesis (IVG), a new, experimental technique that allows scientists to grow embryos in a lab by reprograming adult cells to become sperm and egg cells.
The Football Players Health Study at Harvard University today released a set of legal and ethical recommendations to address a series of structural factors that affect NFL player health. The Football Players Health Study is a research initiative composed of several ongoing studies examining the health and wellbeing of NFL players.